Molecular mechanism of doxorubicin-induced anticholinergic effect in guinea-pig atria

Canadian Journal of Physiology and Pharmacology

Volumn 78, Issue 6, 2000, Pages 483-489

  Hara, Yukio ^a   Temma, Kyosuke ^a   Sekiya, Zin ^a   Chugun, Akihito ^a   Kondo, Hiroshi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Action potential duration; Anticholinergic action; Atrial cell; Doxorubicin; The muscarinic acetylcholine receptor operated K+ current

Indexed keywords

DOXORUBICIN;

ANIMAL TISSUE; ANTICHOLINERGIC EFFECT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; GUINEA PIG; HEART ATRIUM; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; INOTROPISM; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; VOLTAGE CLAMP;

EID: 0033949532     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y00-013     Document Type: Article

References (38)

1. Azuma, J., Sperelakis, N., Hasegawa, H., Tanimoto, T., Vogel, S., Ogura, K., Awata, N., Sawamura, A., Harada, H., Ishiyama, T., Morita, Y., and Yamamura, Y. 1981. Adriamycin cardiotoxicity: possible pathogenic mechanisms. J. Mol. Cell. Cardiol. 13: 381-397.
2. Benjamin, R.S., Riggs, C.R. Jr., and Bachur, N.R. 1977. Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Cancer Res. 37: 1416-1420.
3. Bonner, T.I. 1989. The molecular basis of muscarinic receptor diversity. Trends Neurol. Sci. 12: 148-151.
4. Breitwieser, G.E., and Szabo, G. 1985. Uncoupling of cardiac muscarinic and β-adrenergic receptors from ion channels by a guanine nucleotide analogue. Nature (London), 317: 538-540.
5. Brenner, D.E., Galloway, S., Cooper, J., Noone, R., and Hande, K.R. 1985. Improved high-performance liquid chromatography assay of doxorubicin: detection of circulating aglycones in human plasma and comparison with thin layer chromatography. Cancer Chemother. Pharmacol. 14: 139-145.
6. Bristow, M.R., Mason, J.W., Billingham, M.E., and Daniels, J.R. 1981. Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. Am. Heart J. 102: 709-718.
7. Bristow, M.R., Ginsburg, R., Minobe, W., Cubicciotti, R.S., Sageman, W.S., Lurie, K., Billingham, M.E., Harrison, D.C., and Stinson, E.B. 1982. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. New Engl. J. Med. 307: 205-211.
8. Carmeliet, E., and Mubagwa, K. 1986. Desensitization of the acetylcholine induced increase of potassium conductance in rabbit cardiac Purkinje fibres. J. Physiol. (London), 371: 239-255.
9. Combs, A.B., Acosta, D., and Ramos, K. 1985. Effects of doxorubicin and verapamil on calcium uptake in primary cultures of rat myocardial cells. Biochem. Pharmacol. 34: 1115-1116.
10. Doroshow, J.H. 1991. Doxorubicin-induced cardiac toxicity. New Eng. J. Med. 324: 843-845.
11. Ferrero, M.E., Ferrero, E., Gaja, G., and Bernelli-Zazzera, A. 1976. Adriamycin: energy metabolism and mitochondrial oxidations in the heart of treated rabbits. Biochem. Pharmacol. 25: 125-130.
12. Fu, L.-X., Sjögren, K.-G., and Liang, Q.-M., Waagstein, F., Hoebeke, J., and Hjalmarson, Å. 1991. Activity of receptors coupled to guanine nucleotide binding regulatory protein in doxorubicin induced cardiomyopathy. Cardiovasc. Res. 25: 145-150.
13. Gille, L., and Nohl, H. 1997. Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity. Free Radical Biol. Med. 23: 775-782.
14. Goodman, J., and Hochstein, P. 1977. Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin. Biochem. Biophys. Res. Commun. 77: 797-803.
15. Gosalvez, M., Van Rossum, G.D., and Blanco, M.F. 1979. Inhibition of sodium potassium-activated adenosine 5'-triphosphatase and ion transport by adriamycin. Cancer Res. 39: 257-261.
16. Hara, Y., and Nakaya, H. 1995. SD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells. Br. J. Pharmacol. 116: 2750-2756.
17. Harada, H., Cusack, S.J., Olson, R.D., Stroo, W., Azuma, J., Hamaguchi, T., and Schaffer, S.W. 1990. Taurine deficiency and doxorubicin: interaction with the cardiac sarcolemmal calcium pump. Biochem. Pharmacol. 39: 745-751.
18. Hoyano, Y., Furukawa, Y., Oguchi, T., Kasama, M., Imamura, H., and Chiba, S. 1996. Acute presynaptic inhibition by doxorubicin of negative chrono-and inotropic responses to parasympathetic nerve stimulation in isolated, blood-perfused dog atrium. J. Cardiovasc. Pharmacol. 27: 37-41.
19. Inomata, N., Ohno, T., Ishihara, T., and Akaike, N. 1993. Antiarrythmic agents act differently on the activation phase of the ACh-response in guinea-pig atrial myocytes. Br. J. Pharmacol. 108: 111-115.
20. + channel in isolated guinea-pig atrial myocytes. Naunyn-Schmiedebergs Arch. Pharmacol. 339: 244-246.
21. Jensen, R.A. 1986. Doxorubicin cardiotoxicity: contractile changes after long-term treatment in the rat. J. Pharmacol. Exp. Ther. 236: 197-203.
22. + channels in rabbit atrium. J. Physiol. 433: 589-613.
23. Kim, D.-H., Landry III, A.B., Lee, Y.S., and Katz, A.M. 1989. Doxorubicin-induced calcium release from cardiac sarcoplasmic reticulum vesicles. J. Mol. Cell. Cardiol. 21: 433-436.
24. + channel in cell-free membrane of atrial cells. Am. J. Physiol. 251: H681-H684.
25. + channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins. Pflügers Arch. 407: 264-274.
26. + channel current in isolated atrial myocytes and possible role of GTP-binding proteins. Pflügers Arch. 410: 227-233.
27. Lahtinen, R., Kuikka, J., Nousiainen, T., Uusitupa, M., and Lansimies, E. 1991. Cardiotoxicity of epirubicin and doxorubicin: a double-blind randomized study. Eur. J. Haematol. 46: 301-305.
28. Moore, L., Landon, E.J., and Cooney, D.A. 1977. Inhibition of the cardiac mitochondrial calcium pump by adriamycin in vitro. Biochem. Med. 18: 131-138.
29. Mori, K., Hara, Y., Saito, T., Masuda, Y., and Nakaya, H. 1995. Anticholinergic effects of class III antiarrhythmic drugs in guinea-pig atrial cells. Different molecular mechanisms. Circulation, 91: 2834-2843.
30. Nagami, K., Yoshikawa, T., Suzuki, M., Wainai, Y., Anzai, T., and Handa, S. 1997. Abnormal β-adrenergic transmembrane signaling in rabbits with adriamycin-induced cardiomyopathy. Jpn. Circ. J. 61: 249-255.
31. Nakajima, T., Kurachi, Y., Ito, H., Takikawa, R., and Sugimoto, T. 1989. Anticholinergic effects of quinidine, disopyramide, and procainamide in isolated atrial myocytes: mediation by different molecular mechanisms. Cir. Res. 64: 297-303.
32. Olson, R.D., and Mushlin, P.S. 1990. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J. 4: 3076-3086.
33. Ondrias, K., Borgatta, L., Kim, D.-H., and Ehrlich, B.E. 1990. Biphasic effects of doxorubicin on the calcium release channel from sarcoplasmic reticulum of cardiac muscle. Circ. Res. 67: 1167-1174.
34. Pfaffinger, P.J., Martin, J.M., Hunter, D.D., Nathanson, N.M., and Hille, B. 1985. GTP-binding proteins couple cardiac muscarinic receptors to a K channel. Nature (London), 317: 536-538.
35. Temma, K., Akera, T., Chugun, A., Ohashi, M., Yabuki, M., and Kondo, H. 1992. Doxorubicin: an antagonist of muscarinic receptors in guinea-pig heart. Eur. J. Pharmacol. 220: 63-69.
36. Temma, K., Akera, T., Chugun, A., Kondo, H., Hagane, K., and Hirano, S. 1993. Comparison of cardiac actions of doxorubicin, pirarubicin and aclarubicin in isolated guinea-pig heart. Eur. J. Pharmacol. 234: 173-181.
37. 2+ overloading causes the negative inotropic effect of doxorubicin in myocytes isolated from guinea-pig heart. Eur. J. Pharmacol. 322: 235-242.
38. Wu, S.N., Nakajima, T., Yamashita, T., Hamada, E., Hazama, H., Iwasawa, K., Omata, M., and Kurachi, Y. 1994. Molecular mechanism of cibenzoline-induced anticholinergic action in single atrial myocytes: comparison with effect of disopyramide. J. Cardiovasc. Pharmacol. 23: 618-623.